Table 1 Demographics and tumor characteristics of patients
From: Denonvilliers’ fascia acts as the fulcrum and hammock for continence after radical prostatectomy
Group DFS (n = 72) | Group Control (n = 82) | P | |
|---|---|---|---|
Mean ± Std (Range) | |||
Age, years | 67.8 ± 5.0 (58–79) | 69.3 ± 6.5 (54–80) | 0.1 |
BMI | 24.5 ± 2.6 (17.4–30.9) | 24.5 ± 2.7 (16.8–30.3) | 0.9 |
Diagnosis PSA, ng/ml | 16.0 ± 12.5 (0.4–61.0) | 38.9 ± 114.7 (4.1–946.6) | 0.1 |
Prostate volume, ml | 49.2 ± 15.8 (13.5–100.7) | 51.5 ± 18.5 (16.7–122.5) | 0.4 |
Clinical stage, n (%) | 0.8 | ||
T1 | 30 (41.7) | 33 (40.2) | |
T2 | 38 (52.8) | 46 (56.1) | |
T3 | 4 (5.6) | 3 (3.7) | |
Diagnosis Gleason, n (%) | 0.2 | ||
≤ 6 | 31 (43.1) | 26 (31.7) | |
7 | 31 (43.1) | 37 (45.1) | |
≥ 8 | 10 (13.9) | 19 (23.2) | |
Diagnosis method, n (%) | 0.5 | ||
Biopsy | 66 (91.7) | 78 (95.1) | |
TURP | 6 (8.3) | 4 (4.9) | |
IIEF-5 Q2 ≥ 3 pre-surgery, n (%) | 49 (68.1) | 47 (57.3) | 0.2 |
Comorbid condition, n (%) | |||
CAD | 9 (12.5) | 10 (12.2) | 1.0 |
DM | 12 (16.7) | 17 (20.7) | 0.5 |
HBP | 38 (52.8) | 39 (47.6) | 0.5 |
COPD | 8 (11.1) | 4 (4.9) | 0.2 |
CVD | 4 (5.6) | 6 (7.3) | 0.8 |